Adelaide Research & Scholarship: Search

Search

Results 1-8 of 8 (Search time: 0.002 seconds).

previous
1
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2001	Heart failure in older people: the epidemic we had to have	Horowitz, J.; Stewart, S.
	2001	Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure - Results from the ATLAS trial	Massie, B.; Armstrong, P.; Cleland, J.; Horowitz, J.; Packer, M.; Poole-Wilson, P.; Ryden, L.
	2000	Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus	Ryden, L.; Armstrong, P.; Cleland, J.; Horowitz, J.; Massie, B.; Packer, M.; Poole-Wilson, P.
	2004	Effect of Perindopril on platelet nitric oxide resistance in patients with chronic heart failure secondary to ischemic left ventricular dysfunction	Chirkov, Y.; Holmes, A.; Martelli, J.; Horowitz, J.
	2004	Evidence against a major role of angiotensin converting enzyme-related carboxypeptidase (ACE2) in angiotensin peptide metabolism in the human coronary circulation	Campbell, D.; Zeitz, C.; Esler, M.; Horowitz, J.
	2004	Determinants of platelet responsiveness to nitric oxide in patients with chronic heart failure	Anderson, R.; Ellis, G.; Chirkov, Y.; Holmes, A.; Payne, N.; Blackman, D.; Jackson, S.; Lewis, M.; Horowitz, J.; Frenneaux, M.
	1999	Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril on morbidity and mortality in chronic heart failure	Packer, M.; Poole-Wilson, P.; Armstrong, P.; Cleland, J.; Horowitz, J.; Massie, B.; Ryden, L.; Thygesen, K.; Uretsky, B.
	2012	Ramipril sensitizes platelets to nitric oxide: Implications for therapy in high-risk patients	Willoughby, S.; Rajendran, S.; Chan, W.; Procter, N.; Leslie, S.; Liberts, E.; Heresztyn, T.; Chirkov, Y.; Horowitz, J.